Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study
- PMID: 23355498
- PMCID: PMC3626057
- DOI: 10.1093/aje/kws252
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study
Erratum in
-
Re: "Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study".Am J Epidemiol. 2013 Sep 15;178(6):1012. doi: 10.1093/aje/kwt206. Am J Epidemiol. 2013. PMID: 31795538 Free PMC article. No abstract available.
Abstract
Obesity and alcohol interact to increase the risk of death from liver failure in men. In the present study, we aimed to examine whether obesity and alcohol were multiplicative or additive in increasing the risk of hepatocellular carcinoma (HCC) in both men and women. We conducted a prospective, population-based study of 23,712 Taiwanese residents (50.3% men) from 7 townships who underwent an evaluation for liver disease and were followed for 11.6 years for incident HCC. The mean age was 47 (standard deviation, 10) years and the mean body mass index (weight (kg)/height (m)(2)) was 24 (standard deviation, 3). Overall, 305 cases of HCC were identified over 275,126 person-years of follow-up. Age, male sex, alcohol drinking, cigarette smoking, elevated alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus positivity, and diabetes mellitus were each statistically significant predictors of incident HCC in univariate analyses (P < 0.05). Alcohol use and obesity (body mass index ≥30) showed a synergistic association with the risk of incident HCC in both unadjusted analyses (hazard ratio = 7.19, 95% confidence interval: 3.69, 14.00; P < 0.01) and multivariable-adjusted analyses (age, sex, smoking, serum alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus antibody, and diabetes mellitus) (hazard ratio = 3.82, 95% confidence interval: 1.94, 7.52; P < 0.01). Relative excess risks due to interaction, attributable proportion, and synergy index were 4.83, 0.67, and 4.53, respectively, suggesting a multiplicative interaction between alcohol use and obesity. Obesity and alcohol synergistically increase the risk of incident HCC.
Figures


Comment in
-
RE: "Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study".Am J Epidemiol. 2013 Sep 15;178(6):1010-1. doi: 10.1093/aje/kwt202. Epub 2013 Aug 28. Am J Epidemiol. 2013. PMID: 23985130 No abstract available.
-
Author reply: To PMID 23355498.Am J Epidemiol. 2013 Sep 15;178(6):1011-2. doi: 10.1093/aje/kwt205. Am J Epidemiol. 2013. PMID: 24171206 No abstract available.
Similar articles
-
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.Clin Gastroenterol Hepatol. 2010 Oct;8(10):891-8, 898.e1-2. doi: 10.1016/j.cgh.2010.06.027. Epub 2010 Aug 17. Clin Gastroenterol Hepatol. 2010. PMID: 20621202
-
Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.Cancer Causes Control. 2003 Apr;14(3):241-50. doi: 10.1023/a:1023636619477. Cancer Causes Control. 2003. PMID: 12814203
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan.Am J Epidemiol. 2000 Jan 15;151(2):131-9. doi: 10.1093/oxfordjournals.aje.a010180. Am J Epidemiol. 2000. PMID: 10645815
-
[Role of environmental factors in the etiology of hepatocellular carcinoma].Orv Hetil. 2010 Jul 11;151(28):1132-6. doi: 10.1556/OH.2010.28913. Orv Hetil. 2010. PMID: 20570793 Review. Hungarian.
Cited by
-
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.Clin Liver Dis. 2020 Nov;24(4):549-576. doi: 10.1016/j.cld.2020.06.002. Epub 2020 Aug 25. Clin Liver Dis. 2020. PMID: 33012445 Free PMC article. Review.
-
Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.Front Endocrinol (Lausanne). 2023 Jan 12;13:1061091. doi: 10.3389/fendo.2022.1061091. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36714595 Free PMC article.
-
Prevention of hepatocellular carcinoma and monitoring of high-risk patients.Hepatol Forum. 2022 Jan 9;3(1):33-38. doi: 10.14744/hf.2021.2021.0033. eCollection 2022 Jan. Hepatol Forum. 2022. PMID: 35782375 Free PMC article. Review.
-
Obesity and excess weight in early adulthood and high risks of arsenic-related cancer in later life.Environ Res. 2015 Oct;142:594-601. doi: 10.1016/j.envres.2015.07.021. Environ Res. 2015. PMID: 26301739 Free PMC article.
-
PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk.Clin Gastroenterol Hepatol. 2024 Sep;22(9):1858-1866.e4. doi: 10.1016/j.cgh.2024.04.006. Epub 2024 May 9. Clin Gastroenterol Hepatol. 2024. PMID: 38729396 Free PMC article.
References
-
- World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008. (http://www.who.t/healthinfo/global_burden_disease/2004_report_update/en/.... ). (Accessed June 29, 2011).
-
- Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.C. adults. N Engl J Med. 2003;348(17):1625–1638. - PubMed
-
- Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134–1144. - PubMed
-
- Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol. 1997;145(11):1039–1047. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical